Corneal map-dot-fingerprint dystrophy
We’re all in this for good.
- help each other live better and uncover the best ways to manage your health today
- help researchers shorten the path to new treatments tomorrow
How much good can your data do? A whole lot, as co-founder Jamie Heywood explains in this video.
What is corneal map-dot-fingerprint dystrophy?
Corneal map-dot-fingerprint dystrophy is the most common corneal dystrophy. Most patients are asymptomatic and the condition is found on eye examination. Visual symptoms may include blurred vision, double vision, glare, foreign body sensation, or sensitivity to light.
Common symptoms reported by people with corneal map-dot-fingerprint dystrophy
Treatments taken by people for corneal map-dot-fingerprint dystrophy

Let’s build this page together! When you share what it’s like to have corneal map-dot-fingerprint dystrophy through your profile, those stories and data appear here too.
Got a question about living with corneal map-dot-fingerprint dystrophy? Members in the forum might have the answers.
Compare treatments taken by people with corneal map-dot-fingerprint dystrophy

Let’s build this page together! When you share what it’s like to have corneal map-dot-fingerprint dystrophy through your profile, those stories and data appear here too.
Got a question about living with corneal map-dot-fingerprint dystrophy? Members in the forum might have the answers.
Who has corneal map-dot-fingerprint dystrophy on PatientsLikeMe?
- 0 new patients joined this month
- 12 say corneal map-dot-fingerprint dystrophy is their primary condition
| Age | Proportion | # of patients |
|---|---|---|
| <20 | 0 | |
| 20s | 0 | |
| 30s | 1 | |
| 40s | 3 | |
| 50s | 0 | |
| 60s | 1 | |
| 70+ | 6 |
| Age at first symptom | Proportion | # of patients |
|---|---|---|
| 0-19 years | 0 | |
| 20-29 years | 0 | |
| 30-39 years | 0 | |
| 40-49 years | 0 | |
| 50-59 years | 0 | |
| 60-69 years | 0 | |
| 70+ years | 2 |
Distribution of sex
| Sex | Proportion | # of patients |
|---|---|---|
| Male | 2 | |
| Female | 17 |
| Diagnosis status | Proportion | # of patients |
|---|---|---|
| Diagnosed | 3 | |
| Not Diagnosed | 0 |